Abstract
The human DNA polymerase gamma (Pol γ) is responsible for DNA replication in mitochondria. Pol γ is particularly susceptible to inhibition by dideoxynucleoside-based inhibitors designed to fight viral infection. Here, we report crystal structures of the replicating Pol γ–DNA complex bound to either substrate or zalcitabine, an inhibitor used for HIV reverse transcriptase. The structures reveal that zalcitabine binds to the Pol γ active site almost identically to the substrate dCTP, providing a structural basis for Pol γ-mediated drug toxicity. When compared to the apo form, Pol γ undergoes intra- and inter-subunit conformational changes upon formation of the ternary complex with primer/template DNA and substrate. We also find that the accessory subunit Pol γB, which lacks intrinsic enzymatic activity and does not contact the primer/template DNA directly, serves as an allosteric regulator of holoenzyme activities. The structures presented here suggest a mechanism for processivity of the holoenzyme and provide a model for understanding the deleterious effects of Pol γ mutations in human disease. Crystal structures of the mitochondrial DNA polymerase, Pol γ, in complex with substrate or antiviral inhibitor zalcitabine provide a basis for understanding Pol γ-mediated drug toxicity.
Keywords: DNA replication, drug toxicity, human DNA polymerase gamma, mitochondrial toxicity, nucleoside reverse transcriptase inhibitors
Introduction
A human mitochondrion DNA (mtDNA) codes for a subset of components of the oxidative phosphorylation electron transfer chain for ATP synthesis. The integrity of mtDNA is critically important for energy supplies, the cell cycle, and programmed cell death. Mutations in both human mtDNA and mitochondrial DNA polymerase (Pol γ) have been associated with multisystem clinical disorders (Stumpf & Copeland, 2013).
Unlike nuclear DNA polymerases that have specialized functions in either replication or repair, Pol γ is responsible for both mtDNA replication and repair. Human Pol γ holoenzyme consists of a catalytic subunit Pol γA and a dimeric accessory subunit Pol γB. Pol γA possesses all active sites for holoenzyme activities, including polymerization (pol) for DNA synthesis, 3′–5′ exonuclease (exo) for proofreading, and 5′ deoxyribophosphate (5′dRP) lyase for base excision repair. Pol γB has no intrinsic enzymatic activity, but regulates all Pol γA activities in the holoenzyme (Longley et al, 1998; Johnson et al, 2000; Gellon et al, 2008).
Structurally, Pol γ belongs to the DNA Pol I family. Polymerases in this family dissociate from DNA frequently and are therefore unsuitable for efficient highly processive DNA replication. Indeed, Pol γA alone displays low processivity (Graves et al, 1998; Lim et al, 1999). However, in contrast to most Pol I family members, Pol γA has a spacer domain that enables it to associate with Pol γB; the resulting holoenzyme exhibits drastically increased processivity (Graves et al, 1998; Lim et al, 1999). Pol γB enhances the holoenzyme’s processivity by both increasing the affinity of the holoenzyme for DNA and accelerating the DNA synthesis reaction rate (Johnson et al, 2000; Lee et al, 2010b). Pol γB also increases 5′dRP lyase and reduces exonucleolytic activities (Pinz & Bogenhagen, 2006). A crystal structure of apo Pol γ shows that the pol and exo active sites are 35 Å apart, and it is unclear how Pol γB can regulate multiple activities. Pol γA contacts dimeric Pol γB asymmetrically: It interacts extensively with the proximal Pol γB monomer, but only minimally with the distal monomer (Lee et al, 2009). Nevertheless, subunit interactions at the distal monomer region are important for proper functioning of the holoenzyme, as evidenced by the observation that Pol γA mutants (R232G or R232H) that reside at Pol γA–distal Pol γB subunit interface show significantly reduced DNA synthesis activity and elevated exonucleolytic activity. Patients carrying Pol γA mutations R232G/H display muscular and neurological disorders (Ferrari et al, 2005; Kollberg et al, 2006; Lee et al, 2010a; Rouzier et al, 2014). The apo structure provides little insight as to why these mutations give rise to the resulting phenotype.
The error frequency of Pol γ is 10−5 during DNA replication, comparable to other high-fidelity DNA polymerases (Longley et al, 2001; Lee & Johnson, 2006). However, Pol γ displays lower discrimination than its nuclear counterparts against nucleoside analog HIV reverse transcriptase inhibitors (NRTIs), particularly dideoxynucleoside triphosphates (Johnson et al, 2001; Lee et al, 2003). Thus, the NRTIs that inhibit Pol γ result in moderate to life-threatening mitochondrial toxicity (McKenzie et al, 1995; Koczor & Lewis, 2010).
To understand antiviral drug toxicity and Pol γ mutations in human diseases, we determined crystal structures of Pol γ holoenzyme replication complexes, captured with either a substrate or an antiviral agent, zalcitabine. These structures are the first intact multi-subunit DNA replicase captured during DNA synthesis. The structures illustrate how the two subunits coordinate functions in the holoenzyme to achieve high processivity and to regulate pol/exo activities. The structures show that Pol γ binds zalcitabine and a substrate almost identically, providing a molecular basis for Pol γ’s susceptibility to inhibition by dideoxynucleotides. The structures provide new insight in understanding diseases associated with Pol γ mutations that were inexplicable by the apo structure.
Results and Discussion
Overall structure of replicating holoenzyme
Crystals of human Pol γ replicating complexes (∼250 kDa) were formed in the presence of the catalytic subunit Pol γA, the accessory subunit Pol γB, a 24/28-mer primer/template duplex DNA, CaCl2, and a substrate (dCTP), or a NRTI (the triphosphate form of zalcitabine, ddCTP) (Fig1). Pol γB adopts a pyramidal configuration resembling class II aminoacyl tRNA synthetases with domains corresponding to the base, middle, and apex of the pyramid. Pol γA has three domains: a polymerase (pol) domain that has the canonical “right-hand” DNA polymerase fold with subdomains called the thumb, fingers, and palm; an exonuclease (exo) domain; and a spacer domain that lies between pol and exo. The Pol γA spacer domain contains two subdomains: a globular intrinsic processivity (IP) subdomain and an extended accessory-interacting determinant (AID) subdomain that forms a major binding site for Pol γB at the proximal monomer (Supplementary Fig S1). The primer/template DNA is located in a deep positively charged cleft on Pol γA. Relative to the apo holoenzyme, where Pol γA has almost no interaction with the distal Pol γB monomer, the replication complex has significantly enhanced interaction between the distal Pol γB monomer and Pol γA at the R232 region, resulting from DNA-binding-induced conformational changes. The newly formed subunit interface plays an important role in enabling Pol γB to allosterically regulate polymerase and exonuclease activities in the holoenzyme. The structures illustrate the division of functions in a multi-subunit DNA polymerase.
Figure 1.

Structure of Pol γ replication complex
- Pol γ holoenzyme ternary complex contains Pol γA, a dimeric Pol γB with the proximal (green) and the distal monomers (blue), a primer/template (pink/gray) DNA duplex, and an incoming nucleotide.
- Pol γ (shown in electrostatic surface) interaction with primer/template DNA (green).
- Primer/template DNA sequence. The structurally visible region of the primer/template is bolded in the sequences. For convenience, bases are number such that the incoming nucleotide is +1, and the upstream residues are −1, −2, …, n, and the downstream residues +2, +4.
Substrate, inhibitor, and DNA-binding sites
In the replication complex, the substrate dCTP is coordinated by the catalytic residues D890 and D1135 and two metal ions (M2+) in the pol active site bounded by the palm and fingers subdomains (Fig2; Supplementary Fig S2). Although as many as four metal ions are seen in various DNA polymerases, a minimum of two metal ions are critical for the phosphotransfer reaction. One divalent metal ion participates in nucleophilic reaction by reducing the pKa of the attacking group, 3′OH of the primer. The other metal ion stabilizes the leaving group PPi after catalysis (Steitz & Steitz, 1993). As the primer terminus is a nonreactive dideoxynucleotide, the structure represents a pre-chemistry substrate complex (Steitz, 1999). The triphosphate moiety of dCTP is stabilized by R943 and K947 of the O-helix (residues 943–955) in the fingers subdomain (Fig3). The template DNA bends ∼90° at the single-/double-strand junction; the bent conformation is enforced by Y955 and a short connecting loop (957AG958) (Fig2). Compared to apo Pol γ, the O-helix pivots around its center so that R943 and K947 close the active site concurrent with Y955 rotation to facilitate productive dNTP binding (Fig4B). This extreme template bending and Y955 rotation are important to maintain template register, and to reduce slippage and backtracking during replication (Graziewicz et al, 2004; Estep & Johnson, 2011). The open–closed conformational change occurs at each nucleotide addition, as shown in many high-fidelity DNA polymerases (Doublié & Ellenberger, 1998; Steitz & Yin, 2004).
Figure 2.

The pol active site of Pol γ ternary complex
- The pol active site of a Pol γ ternary complex with a substrate dCTP.
- The pol active site of a Pol γ ternary complex with inhibitor ddCTP (zalcitabine).
Figure 3.

Schematic representation of Pol γ–DNA interactions
Residues are color-coded with exo domain residues in black, spacer domain: IP subdomain in yellow, AID subdomain in orange, pol domain containing subdomains palm (red), fingers (blue) and thumb (green).
Figure 4.

Conformational changes induced by DNA binding
- The K-tract region moves 25 Å from its position in the apo enzyme (light colors) to the replication complex (solid colors).
- The fingers move 20° (10 Å) from the open conformation in apo (light blue) to the closed form in the complex (dark blue).
The DNA duplex is bound exclusively to Pol γA in a deep crevice formed by the spacer and pol domains, adopting the A-form in the active site, and transforming to B-form around base pair −4. All subdomains of Pol γA pol domain participate in interacting with the primer/template DNA (Fig3). The thumb binds the minor groove of the duplex at the −5 to −7 positions, and a cluster of positively charged residues, R802, K806, and R807, forms electrostatic interactions with the DNA backbone (Figs3 and 4A; Supplementary Fig S3). These interactions made us predict that the thumb forms firm grip on the DNA duplex such that movements of the thumb are coupled to movements of the primer terminus.
Additional DNA interactions are formed with the spacer domain: The IP subdomain binds the primer strand at positions −3 to −5. Together with pol, the IP subdomain encircles the primer/template, reducing enzyme dissociation from the DNA. The flexible AID subdomain contains a lysine-rich K-tract that interacts with the negatively charged phosphodiester backbone (Fig4A). Binding to Pol γB stabilizes the flexible AID subdomain and increases the holoenzyme DNA-binding area to 20 bp from that of 10 bp with Pol γA alone. The increased interaction provides a structural basis for Pol γB increasing DNA affinity in the holoenzyme.
The replication complex containing ddCTP shows that the inhibitor is bound nearly identically as dCTP (Fig2; Supplementary Fig S2), providing a structural basis for the high toxicity for ddN-based antiviral inhibitors. In both structures, Y951 stacks with the incoming nucleotide, with its –OH group that is 3.5 Å from O3′ and C2′ of the deoxyribose moiety. The hydroxyl group of Y951 is the main source of drug toxicity, because the Pol γA Y951F mutant exhibits significantly reduced sensitivity to ddN (Lim et al, 2003; Graziewicz et al, 2004). E895 is situated in the pol site, and its ε-oxygen is 3.4 and 4.3 Å from the C2′ and O3′ of the ribose moiety of dCTP, confirming its contributions to rNTP and minor ddNTP discrimination (Supplementary Fig S4). In Pol I family members, this residue, conserved as either a Phe or Tyr, is important for substrate sugar moiety specificity (Tabor & Richardson, 1995; Astatke et al, 1998; Feng et al, 2004). Although both Phe and Tyr are able to discriminate against the ribonucleotides that are structurally larger than dNTP, only Phe exhibits selectivity against smaller ddNTP (Tabor & Richardson, 1995; Astatke et al, 1998; Wang et al, 2012). Pol γA Y951F substitution is likely to cause a slight misalignment of the O-helix, resulting in exclusion of ddNTP in a fashion similar to that shown in bacillus DNAP ternary complexes (Wang et al, 2012).
DNA induced intra- and inter-subunit structural changes
Upon binding to DNA, the holoenzyme undergoes conformational changes that reveal the mechanism for holoenzyme processivity and pol and exo activity regulation. In the apo enzyme, the subunit interface is formed between proximal Pol γB monomer and Pol γA L-helix in the AID and the thumb subdomains; only a single salt bridge exists between R232 and E394 of the distal Pol γB monomer (Fig5A and B). Formation of a productive replication complex results in conformational changes at the subunit interface: Pol γB rotates by 22° toward pol of Pol γA. However, the rotation does not alter the interface of Pol γA–Pol γB proximal monomer because the thumb and the L-helix of Pol γA rotate together with Pol γB as a single rigid body, despite being on separate polypeptide chains. These conformational changes bring the Pol γB distal monomer 16 Å closer to Pol γA in the R232 region (Fig5C). Consequently, a more substantial subunit interaction is formed between Pol γA and distal Pol γB monomer; the contact surface area increases from 226 Å2 in the apo enzyme to 1,610 Å2 in the ternary replication complex. Using the conversion factor of 25 cal per Å2 contact surface area (Richards, 1977), the conformational changes enhance the interaction of Pol γA with the distal Pol γB monomer by 34 kcal. Importantly, Pol γA R232 is situated in a pocket of the distal Pol γB, forming H-bonds with H467 and S469, and Pol γA W235 forms hydrophobic interactions with Pol γB V338 (Fig5C). The replication complex adopts a more compact structure than apo Pol γ in good agreement with solution measurement performed by small-angle X-ray scattering (He et al, 2013). While Pol γA displays several intra-subunit-independent structural changes in the fingers, thumb and L-helix, and the IP subdomains, Pol γB shows no internal structural changes and moves as a rigid body. The locations of Pol γB and the Pol γA thumb in the replication complex orient the primer terminus in pol and away from exo, tilting the pol/exo activity balance toward replication. The structure provides an explanation for the deleterious effects on mtDNA synthesis in patients carrying Pol γA R232 substitutions and highlights the importance of an intact Pol γA–distal Pol γB monomer interface for mitochondrial DNA replication.
Figure 5.

The inter-subunit conformational changes from apo to ternary complex
- Pol γB and its binding elements in Pol γA, the thumb and the L-helix rotate 22° as a rigid body.
- The distal Pol γB monomer moves 16 Å from its position in apo to complex position as shown in (C).
- The complex.
The two subdomains in the spacer undergo different modes of structural changes upon binding to DNA (Figs4A and 5A). The IP globular subdomain clamps down on the DNA duplex toward the 3′-end of the primer, enlarging the Pol γA DNA-binding site, whereas the AID subdomain undergoes more complex changes. The lysine-rich K-tract binds DNA duplex in the minor groove at base pairs −20 to −22 (Figs3 and 4A), and additional interactions are seen between AID and the distal Pol γB monomer (Fig4A). These structural changes are consistent with solution studies where binding to DNA strengthens the affinity of Pol γA for Pol γB (Lee et al, 2010b). A pre-steady state kinetic study reported that Pol γ exhibits reduced synthesis rate on a 18-nt primer, which is sevenfold slower than that on a 24-nt primer (3.2 nt s−1 versus 22 nt s−1) (Murakami et al, 2003), in good agreement with our structural results.
To confirm our structural results, we substituted each lysine in the K-tract to cysteine and analyzed the pre-steady state kinetics of multiple nucleotide addition by Pol γ variants using primer/template substrate in the presence of all dNTPs. The rationale for the substitutions was to examine the effect of positive-charge changes on DNA synthesis activity. 25-nt primer was used as Pol γ synthesis rate on primers 25 nt or longer provided maximum reaction rate, as analyses using longer primers (up to 37 nt) showed that Pol γ replication proceeds at comparable rate as on the 25-nt primer. Thus, 25-nt primer is the minimal length primer that enables the maximum reaction rate for Pol γ. Pol γA elongates the primer at an average rate of 14 nt s−1, whereas Pol γ holoenzyme is more efficient at an average rate of 43 nt s−1. This processive elongation rate of the holoenzyme is very similar to the rate of single-nucleotide addition reported in the literature (Estep & Johnson, 2011). The K-tract substitutions (K498C, K499C, and K501C) have a significant effect on the activity of both Pol γA and holoenzyme (Fig6). In the absence of Pol γB, the mutants add the first nucleotide rapidly, but subsequent nucleotides are added at two- to fivefold slower rates relative to wild-type. Therefore, in these mutants, there is visible accumulation of the one-nucleotide elongation product even in the presence of all dNTPs. The addition of Pol γB partially rescues this defect of the Pol γA mutants and there is relatively less stalling after the addition of one nucleotide, but the mutant proteins remain less processive. Consequently, they synthesize DNA at three- to fivefold slower rates relative to wild-type. The rest of the K-tract mutants show similar activity as the wild-type (Fig6). Overall, the results indicate that the K-tract is not directly involved in the nucleotide addition catalytic activity, but the inability to interact with upstream DNA decreases the processivity of DNA synthesis. Interestingly, this defect is observed in lysines that are close to mutation Q497H substitution, which is associated with Alpers syndrome (Winterthun et al, 2005).
Figure 6.

Pre-steady state kinetics assays of K-tract mutants
Assays were performed on the 65-nt DNA template annealed to a 5′-32P-labeled 25-nt primer and initiated by the addition of dNTPs. DNA synthesis products synthesized by Pol γA variants alone (top panels) or holoenzymes (bottom panels).
Communication between pol and exo sites
An incorporated NRTI is technically an incorrect nucleotide and should therefore provoke proofreading by Pol γ exonuclease. However, the most toxic nucleotide analog inhibitors, including ddC, are hydrolyzed at significantly slower rates than drugs with lower toxicity, indicating that exo contributes to Pol γ-mediated drug toxicity (Feng et al, 2001; Lim & Copeland, 2001).
The exo domain (residues 170–440) of Pol γ is both spatially separated and structurally distinct from pol; the two active sites are 35 Å apart and exo consists of an array of antiparallel β-sheets sandwiched between α-helices (Fig7A). This configuration of exo and its distance from pol are generally conserved in other members of the DNA Pol I family. When pol incorporates an incorrect nucleotide, the 3′-end has to move to exo for excision. There must therefore be a mechanism to link recognition of a misincorporation event to shuttling of the 3′-end to exo.
Figure 7.

Regulator for pol and exo activity
- The β-hairpin is situated between pol and exo active sties and is connected to the thumb subdomain. R852 interacts with residues on the fingers subdomain.
- R853 forms H-bonds with the nascent bp of incoming nucleotide and the template residue (T+1).
- Upstream, R853 interacts with bp of the T-1 template and P-1 primer residues.
Analysis of the Pol γ–DNA structure suggests that an antiparallel hairpin, consisting of residues 835–858, could perform this function. The hairpin is located between pol and exo, and the hairpin tip contains two adjacent arginines in a conserved hexapeptide 851TRRAVE856 (Fig7; Supplementary Fig S5). In the Pol γ replicating complex, R853 reaches into pol and forms an H-bond with base pair −1 in the minor groove, as well as with the incoming nucleotide at the +1 position (Fig7B and C; Supplementary Fig S6). These H-bonds can serve as checkpoints for correct Watson–Crick (W-C) base complementarity. The other conserved arginine, R852, points away from the DNA duplex and is embedded in a deep protein core, forming bipartite H-bonds with residues K1107 and S1103 in a helix of the fingers subdomain (Fig7). These interactions may be important in positioning R853. The base of the connecting hairpin is close to the thumb and thus could be able to sense both the thumb rotation and the fingers open–close conformational changes that occur during nucleotide incorporation. These structural features lead us to hypothesize that the antiparallel hairpin may physically and functionally link the base complementarity check with, in the case of misincorporation, shuttling the primer end from pol to exo. In support of this idea, Pol γA substitutions at R852 and R853 were found to dramatically reduce polymerase activity and, not surprisingly, are associated with mitochondrial disorders: Patients carrying Pol γA R852C/H display increased mtDNA mutations, and Parkinsonism patients carrying R853W/Q show multiple mtDNA deletions (Davidzon et al, 2006; Gonzalez-Vioque et al, 2006; Kasiviswanathan et al, 2009; Vasta et al, 2012). In silico, the substitutions R852C/H abrogate the H-bonds that facilitate positioning R853, whereas substitution of R853 with the bulkier tryptophan residue abolishes the important H-bond with the −1 base pair. The loss of this checkpoint for base complementarity in pol could increase the mutation rate, and/or cause slippage during replication.
The antiparallel hairpin is spatially conserved in other Pol I family members. The Pol γA R853 that performs the minor groove checking at base pair −1 is conserved as R429 and R668 in T7 DNAP and E. coli Pol I, respectively (Doublié et al, 1998). The amino acid composition of this hairpin is one of the most conserved sequences in known bacterial Pol I family enzymes (TGRLSSXXPNLQNIP, the conserved R is bolded), and the sequence of the antiparallel hairpin in Pol γ is highly conserved in mitochondrial polymerases from invertebrates to mammals (Supplementary Fig S5), suggesting a common and important function.
This β-hairpin is seemingly structurally conserved even in polymerases with proofreading activity from other families, such as the Pol B family members bacteriophage RB69 and T4 DNA polymerases (Hogg et al, 2007; Subuddhi et al, 2008). Studies of the synthesis and editing complexes of RB69 identified a β-hairpin that appears to perform the same function. The β-hairpin of RB69 is located on the surface of the molecule and, although different from Pol γ, may serve as a communicator between the pol and exo sites (Hogg et al, 2007; Subuddhi et al, 2008). Additional residues, typically conserved Gln and Asn in Pol I family polymerases, also participate in minor groove readout: Q1102 and N1098 in Pol γ, Q615 and N611 in T7 DNAP, and Q745 and N750 in Taq DNAP. The linearly aligned Arg, Gln, and Asn extend the entire distance of the minor groove of the nascent base pair and are predicted to be critically important to maintain DNA synthesis fidelity.
Allosteric regulatory switch for pol/exo activities
The conformational changes in the replication complex suggest a structural mechanism for pol/exo activity regulation by Pol γA–distal Pol γB interface. Mutations on both subunits in this region display severe loss of function in patients. In addition to the Pol γA R232G/H mutant holoenzymes as discussed above, the Pol γB G451E substitution, located in the same interface in the replication complex, shows equivalently decreased synthesis and increased nucleolytic activity defects as the Pol γA R232-containing holoenzyme (Longley et al, 2006; Lee et al, 2010a; Young et al, 2011). Pol γB G451E has a severely reduced association with Pol γA, which decreases the stimulation of catalytic activity and processivity (Longley et al, 2006; Young et al, 2011). Both G451 residues in the Pol γB dimer interact with Pol γA in the replication complex, and therefore, the substitution weakens the holoenzyme: The distal G451E causes a steric clash with E230 of Pol γA, whereas the proximal G451E weakens the interaction with the hydrophobic Pol γA L-helix (Fig8). These studies strongly suggest that the interaction between Pol γA and the distal Pol γB monomer is critical for holoenzyme pol activity and that disruption of the subunit interface favors binding of the primer in exo. Lack of such interaction in the holoenzyme containing Pol γB G451E substitution makes it structurally resemble the apo enzyme. To investigate this idea, we modeled the transition of Pol γ holoenzyme from the apo to the ternary complex, assuming that the DNA binding to the thumb was unchanged. The resulting complex positions the 3′-end of the primer away from pol and 16 Å closer to exo (Supplementary Fig S7). This exercise suggests that interactions between Pol γA and distal Pol γB monomer contribute to pol/exo activity regulation. The model thus provides a structural explanation for how Pol γB can simultaneously regulate both pol and exo activities by serving as an allosteric regulator through dynamic interactions at the Pol γA–distal Pol γB interface.
Figure 8.

Structural rationalization of deleterious Pol γ mutations implicated in human diseases
- Pol γB G451E mutations illustrated on the structure of the holoenzyme replication complex.
- The proximal monomer G451E interacts with the L-helix of Pol γA.
- The distal monomer G451E interacts with the Pol γA R232 region.
The ternary structures of Pol γ presented here are the first intact human multi-subunit replicating complexes. The structures reveal that the holoenzyme possesses a strong inter-subunit core that maintains the constant contacts between the catalytic subunit Pol γA and the proximal monomer of Pol γB, which are necessary for highly processive DNA synthesis, but leaves the Pol γA–distal Pol γB monomer interface dynamic, such that the interface can regulate both DNA synthesis and proofreading. Thus, the Pol γA–distal Pol γB monomer interface functions as an allosteric regulator for pol and exo activities. We show that the nucleoside inhibitor designed against HIV reverse transcriptase binds to Pol γ almost identically as the substrate, providing a structural basis for Pol γ’s susceptibility to inhibition by dideoxynucleotides. These structures provide a literal and conceptual framework for assessing the impact of Pol γ mutations implicated in mitochondrial diseases.
Materials and Methods
Cloning and expression
Wild-type and exonuclease-deficient (exo−), D198A/E200A Pol γA, lacking residues 1–29 (mitochondrial localization sequence) and 10 of the 13 sequential glutamines (residues 43–52), were placed in pET22b(+) (Novagen). K-tract (496KQKKAKKVKK505) mutants were produced by substituting each lysine to cysteine in exo− Pol γA using the QuikChange kit (Stratagene), resulting in exo− Pol γA K496C, K498C, K499C, K501C, K502C, K504C, and K506C. Clones were transferred into the baculovirus genome using the shuttle vector pBacPak9 (Clontech) The C-terminal His-tagged proteins were synthesized in Sf9 insect cells (Invitrogen), grown at 27°C in SF900-II SFM growth medium, and infected at a density of 1–2 × 106 cells/ml. Cells were harvested 72 h post-infection. Selenomethionine-substituted exo− Pol γA was purified by a modification of our earlier protocol (Lee et al, 2009). In brief, SF-900 II SFM growth medium (Invitrogen) was exchanged 12 h after infection with unsupplemented Grace’s insect medium (Invitrogen), and 50 mg/l L-(+)-Se-Met (Acros) was added. Cells were harvested 48 h after medium exchange. Pol γΒ-ΔI4 was expressed and purified as described (Lee et al, 2009). Selenomethionine-substituted Pol γΒ-ΔI4 was expressed in E. coli B834(DE3) RIL (Novagen) in M9 minimal media supplemented with 100 mg/l L-(+)-Se-Met (Acros).
Protein purification
Pol γA wild-type and variants Pol γA exo−, K496C, K498C, K499C, K501C, K502C, K504C and K506C, and Pol γΒ wild-type and variant ΔI4 were purified by sequential application to TALON (Clontech) for Pol γA exo− and Ni-NTA agarose (Qiagen) for Pol γB-ΔI4, SOURCE S, and Superdex 200 columns (Lee et al, 2009). Selenomethionine-substituted exo− Pol γA and Pol γΒ-ΔI4 were purified similarly. Holoenzyme used for crystallization is formed by combining exo− Pol γA and Pol γB-ΔI4 at a 1:2 molar ratio and isolation on Superdex 200. The peak fractions corresponding to 240-kDa complex were pooled and verified by SDS–polyacrylamide gel electrophoresis (SDS–PAGE). Proteins were judged to be ∼98% pure. Concentrations of Pol γA and Pol γΒ were determined spectrophotometrically using extinction coefficients: ε280 = 2.4379 × 105 M−1 cm−1 and 1.4388 × 105 M−1 cm−1, respectively.
Preparation and crystallization of the Pol γAB–DNA–nucleotide complex
Synthetic DNA oligonucleotides were obtained from Midland Certified (Midland, TX) and IDT (Coralville, Iowa). Nucleic acid scaffolds (Fig1C) were mixed at equimolar concentrations of template and primer to a final concentration of 1 mM of primer/template DNA and were then annealed by heating to 95°C and slowly cooling to room temperature. ddCTP and dCTP were purchased from TriLink BioTechnologies (San Diego, CA). For crystallization, the exo− Pol γA and Pol γB-ΔI4 complex (40–65 μM) was formed with 1 mM CaCl2, 1 mM ddCTP or dCTP, and 24/28-mer primer/template DNA (60–95 μM) and incubated on ice for ∼15 min. Crystals were obtained using the sitting-drop method by mixing the complex at 1:1 volume ratio with a solution: 3% PEG 8000, 150 mM NaCl, 10 mM CaCl2, 100 mM MES pH 6, 2 mM 2-mercaptoethanol, 0.8 M NDSB-201, 1–6% sucrose, and 2% Jeffamine M-600. Crystallization experiments were performed against a well solution containing 3% PEG 8000, 150 mM NaCl, 10 mM CaCl2, 100 mM MES pH 6, and 2 mM 2-mercaptoethanol at 20°C. Crystals grew to a maximum size of 0.4 × 0.2 × 0.2 mm within 2–4 days. Selenomethionine-substituted exo− PolγAΒΔI4–DNA-ddCTP was grown similarly except that 2-mercaptoethanol was 50 mM. Before freezing in liquid nitrogen, crystals were cryo-protected by adding a mixture of glycerol and MPD (≤ 20% final) and 1 mM ddCTP/dCTP into the crystallization drop.
Data collection, refinement, and structural determination
X-ray diffraction data were collected at 100 K using synchrotron sources at Advanced Photon Source and Advanced Light Source. Single wavelength anomalous dispersion (SAD) diffraction data were collected at peak of the Se anomalous wavelength (0.979 Å) using the inverse beam method, and the native data were collected at 1.0 Å wavelength. Diffraction data sets were processed with HKL (Minor et al, 2006), and data collection statistics are shown in Table1. The structures were determined using combined phases from molecular replacement and SAD. Forty-two (of 46 total) Se atoms in the holoenzyme were identified, and the combined phases gave a figure of merit 0.704. Phases were further improved by density modification. The final structure was refined using Phenix (Adams et al, 2010). The experimental map clearly illustrates density for the double-helical DNA structure (Supplementary Fig S8), and enabled rebuilding of the regions that had undergone structural changes induced by DNA binding. Disordered regions of the holoenzyme are mainly located in the N- or C- terminal and fingers regions. These regions include residues 30–76, 248–261, 317–342, 663–740, 996–1,051, and 1,230–1,239. The disordered regions in Pol γB involve 116 aa in the dimer and again are the same in both structures. They include residues 26–67, 222–228, and 356–361 in chain B and 26–66, 220–226, and 356–367 in chain C.
Table 1.
Data collection and refinement statistics
| Se-Met ddCTP | Native ddCTP | Native dCTP | |
|---|---|---|---|
| Wavelength (Å) | 0.979 Å | 1.0 Å | 1.0 Å |
| Resolution range (Å) | 46.14–3.549 (3.676–3.549) | 48.68–3.29 (3.48–3.29) | 48.48–3.459 (3.718–3.459) |
| Space group | P 41 21 2 | P 41 21 2 | P 41 21 2 |
| Unit cell | 215.62 215.62 159.14890 90 90 | 217.686 217.686 168.4990 90 90 | 216.167 216.167 162.7290 90 90 |
| Total reflections | 5,055,152 | 961,381 | 1,882,186 |
| Unique reflections | 45,635 (4,315) | 61,142 (5,694) | 53,256 (4,441) |
| Multiplicity | 37.5 | 3.1 | 5.8 |
| Completeness (%) | 99.60 (96.00) | 99.50 (99.96) | 99.64 (98.60) |
| Mean I/sigma(I) | 18.09 (3.13) | 21.52 (2.07) | 18.53 (2.87) |
| R-merge | 0.092 | 0.067 | 0.096 |
| R-work | 0.2868 (0.3971) | 0.2812 (0.3783) | 0.2842 (0.4126) |
| R-free | 0.3164 (0.4253) | 0.3280 (0.4131) | 0.3074 (0.4310) |
| Number of atoms | 14,632 | 14,632 | 14,633 |
| Macromolecules | |||
| Proteins | 13,622 | 13,622 | 13,622 |
| Nucleic acids | 983 | 983 | 983 |
| Ligand | |||
| Nucleotides triphosphate | 27 | 27 | 28 |
| Divalent metal ions | 2 | 2 | 2 |
| Water | 0 | 0 | 0 |
| Number of residues | |||
| Protein residues | 1,741 | 1,741 | 1,741 |
| Nucleic acid residues | 47 | 47 | 47 |
| Nucleotides triphosphate | 1 ddCTP | 1 ddCTP | 1 dCTP |
| RMS (bonds) (Å) | 0.004 | 0.004 | 0.003 |
| RMS(angles) (°) | 1.13 | 0.88 | 0.79 |
| Ramachandran favored (%) | 95 | 99.3 | 99.0 |
| Ramachandran outliers (%) | 4.9 | 0.69 | 0.98 |
| Clashscore | 18.54 | 11.75 | 10.8 |
| Average B-factor | 58.30 | 53.66 | 61.57 |
| Macromolecules | 49.40 | 46.30 | 57.60 |
| Nucleic acids | 86.90 | 82.20 | 99.30 |
Statistics for the highest resolution shell are shown in parentheses.
Kinetic assays
Pre-steady state polymerization assays were carried out using RQF-3 Rapid Chemical Quench Flow instrument (KinTek Co.). Briefly, reactions were initiated by rapid mixing of a pre-incubated Pol γAΒ–DNA complex (200 nM Pol γA, 800 nM Pol γB) and 50 nM primer/template DNA with 5′-32P-labeled primer with 1 mM dNTP, 10 mM MgCl2 in buffer containing 50 mM Tris acetate pH 7.5, 50 mM potassium glutamate, 0.05% Tween-20, 5% glycerol, and 2 mM DTT. Reactions were incubated at 37°C before being quenched with 0.5 M EDTA. The resulting polymerization patterns were resolved using 24% denaturing PAGE and were visualized by autoradiography. The reactions were carried out with a 65-mer template (CATATTAATTATGATATAGACCCATAATTATATTACTTAGTTGAATCTCTTCCACTAACCAGCGC) annealed to a 25-mer primer (GCGCTGGTTAGTGGAAGAGATTCAA). Each of the DNA bands up to 17-nt additions was quantified and summed to estimate the number of nucleotides added in each reaction time, and the slopes after one-nucleotide addition are provided as estimates of the DNA synthesis rates.
Accession numbers
‘The coordinates of the structures reported here have been deposited in the Protein Data Bank (accession numbers 4ZTU and 4ZTZ).
Acknowledgments
We thank I Molineux and J Lee and M Morais for critical reading and editing of the manuscript. We thank staff at the beamlines 19-ID and 19-BM at the Advanced Photon Source, Argonne National Laboratory, Argonne, IL, and beamlines 8.8.2 and 8.2.1 at the Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, CA. The work is supported by grants from NIH (GM 083703 and GM110591) and Welch Foundation (H-1592) to YWY, and NIH (GM55310) to SSP. MRS was partially supported by the J. B. Kempner Postdoctoral Fellowship.
Author contributions
MRS, VBK, CS, QM, Y-SL, and YWY designed and performed the experiments and analyzed the experimental results. SP and GP performed and analyzed the kinetic data. MRS, SP, and YWY wrote the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Supporting Information
Supplementary Figures
Review Process File
References
- Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Astatke M, Grindley ND, Joyce CM. How E. coli DNA polymerase I (Klenow fragment) distinguishes between deoxy- and dideoxynucleotides. J Mol Biol. 1998;278:147–165. doi: 10.1006/jmbi.1998.1672. [DOI] [PubMed] [Google Scholar]
- Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, Hirano M, DiMauro S. Early-onset familial Parkinsonism due to POLG mutations. Ann Neurol. 2006;59:859–862. doi: 10.1002/ana.20831. [DOI] [PubMed] [Google Scholar]
- Doublié S, Ellenberger T. The mechanism of action of T7 DNA polymerase. Curr Opin Struct Biol. 1998;8:704–712. doi: 10.1016/s0959-440x(98)80089-4. [DOI] [PubMed] [Google Scholar]
- Doublié S, Tabor S, Long AM, Richardson CC, Ellenberger T. Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 A resolution. Nature. 1998;391:251–258. doi: 10.1038/34593. [DOI] [PubMed] [Google Scholar]
- Estep PA, Johnson KA. Effect of the Y955C mutation on mitochondrial DNA polymerase nucleotide incorporation efficiency and fidelity. Biochemistry. 2011;50:6376–6386. doi: 10.1021/bi200280r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feng JY, Johnson AA, Johnson KA, Anderson KS. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. J Biol Chem. 2001;276:23832–23837. doi: 10.1074/jbc.M101156200. [DOI] [PubMed] [Google Scholar]
- Feng JY, Murakami E, Zorca SM, Johnson AA, Johnson KA, Schinazi RF, Furman PA, Anderson KS. Relationship between antiviral activity and host toxicity: comparison of the incorporation efficiencies of 2′,3′-dideoxy-5-fluoro-3′-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase. Antimicrob Agents Chemother. 2004;48:1300–1306. doi: 10.1128/AAC.48.4.1300-1306.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ferrari G, Lamantea E, Donati A, Filosto M, Briem E, Carrara F, Parini R, Simonati A, Santer R, Zeviani M. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain. 2005;128:723–731. doi: 10.1093/brain/awh410. [DOI] [PubMed] [Google Scholar]
- Gellon L, Carson DR, Carson JP, Demple B. Intrinsic 5′-deoxyribose-5-phosphate lyase activity in Saccharomyces cerevisiae Trf4 protein with a possible role in base excision DNA repair. DNA Repair. 2008;7:187–198. doi: 10.1016/j.dnarep.2007.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gonzalez-Vioque E, Blazquez A, Fernandez-Moreira D, Bornstein B, Bautista J, Arpa J, Navarro C, Campos Y, Fernandez-Moreno MA, Garesse R, Arenas J, Martin MA. Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population. Arch Neurol. 2006;63:107–111. doi: 10.1001/archneur.63.1.107. [DOI] [PubMed] [Google Scholar]
- Graves SW, Johnson AA, Johnson KA. Expression, purification, and initial kinetic characterization of the large subunit of the human mitochondrial DNA polymerase. Biochemistry. 1998;37:6050–6058. doi: 10.1021/bi972685u. [DOI] [PubMed] [Google Scholar]
- Graziewicz MA, Longley MJ, Bienstock RJ, Zeviani M, Copeland WC. Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegia. Nat Struct Mol Biol. 2004;11:770–776. doi: 10.1038/nsmb805. [DOI] [PubMed] [Google Scholar]
- He Q, Shumate CK, White MA, Molineux IJ, Yin YW. Exonuclease of human DNA polymerase gamma disengages its strand displacement function. Mitochondrion. 2013;13:592–601. doi: 10.1016/j.mito.2013.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hogg M, Aller P, Konigsberg W, Wallace SS, Doublié S. Structural and biochemical investigation of the role in proofreading of a beta hairpin loop found in the exonuclease domain of a replicative DNA polymerase of the B family. J Biol Chem. 2007;282:1432–1444. doi: 10.1074/jbc.M605675200. [DOI] [PubMed] [Google Scholar]
- Johnson AA, Tsai Y, Graves SW, Johnson KA. Human mitochondrial DNA polymerase holoenzyme: reconstitution and characterization. Biochemistry. 2000;39:1702–1708. doi: 10.1021/bi992104w. [DOI] [PubMed] [Google Scholar]
- Johnson AA, Ray AS, Hanes J, Suo Z, Colacino JM, Anderson KS, Johnson KA. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J Biol Chem. 2001;276:40847–40857. doi: 10.1074/jbc.M106743200. [DOI] [PubMed] [Google Scholar]
- Kasiviswanathan R, Longley MJ, Chan SS, Copeland WC. Disease mutations in the human mitochondrial DNA polymerase thumb subdomain impart severe defects in mitochondrial DNA replication. J Biol Chem. 2009;284:19501–19510. doi: 10.1074/jbc.M109.011940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koczor CA, Lewis W. Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA. Expert Opin Drug Metab Toxicol. 2010;6:1493–1504. doi: 10.1517/17425255.2010.526602. [DOI] [PubMed] [Google Scholar]
- Kollberg G, Moslemi AR, Darin N, Nennesmo I, Bjarnadottir I, Uvebrant P, Holme E, Melberg A, Tulinius M, Oldfors A. POLG1 mutations associated with progressive encephalopathy in childhood. J Neuropathol Exp Neurol. 2006;65:758–768. doi: 10.1097/01.jnen.0000229987.17548.6e. [DOI] [PubMed] [Google Scholar]
- Lee H, Hanes J, Johnson KA. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry. 2003;42:14711–14719. doi: 10.1021/bi035596s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee HR, Johnson KA. Fidelity of the human mitochondrial DNA polymerase. J Biol Chem. 2006;281:36236–36240. doi: 10.1074/jbc.M607964200. [DOI] [PubMed] [Google Scholar]
- Lee YS, Kennedy WD, Yin YW. Structural insights into human mitochondrial DNA replication and disease-related polymerase mutations. Cell. 2009;139:312–324. doi: 10.1016/j.cell.2009.07.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee YS, Johnson KA, Molineux IJ, Yin YW. A single mutation in human mitochondrial DNA polymerase Pol gammaA affects both polymerization and proofreading activities of only the holoenzyme. J Biol Chem. 2010a;285:28105–28116. doi: 10.1074/jbc.M110.122283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee YS, Lee S, Demeler B, Molineux IJ, Johnson KA, Yin YW. Each monomer of the dimeric accessory protein for human mitochondrial DNA polymerase has a distinct role in conferring processivity. J Biol Chem. 2010b;285:1490–1499. doi: 10.1074/jbc.M109.062752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lim SE, Longley MJ, Copeland WC. The mitochondrial p55 accessory subunit of human DNA polymerase gamma enhances DNA binding, promotes processive DNA synthesis, and confers N-ethylmaleimide resistance. J Biol Chem. 1999;274:38197–38203. doi: 10.1074/jbc.274.53.38197. [DOI] [PubMed] [Google Scholar]
- Lim SE, Copeland WC. Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J Biol Chem. 2001;276:23616–23623. doi: 10.1074/jbc.M101114200. [DOI] [PubMed] [Google Scholar]
- Lim SE, Ponamarev MV, Longley MJ, Copeland WC. Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs. J Mol Biol. 2003;329:45–57. doi: 10.1016/s0022-2836(03)00405-4. [DOI] [PubMed] [Google Scholar]
- Longley MJ, Ropp PA, Lim SE, Copeland WC. Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity. Biochemistry. 1998;37:10529–10539. doi: 10.1021/bi980772w. [DOI] [PubMed] [Google Scholar]
- Longley MJ, Nguyen D, Kunkel TA, Copeland WC. The fidelity of human DNA polymerase gamma with and without exonucleolytic proofreading and the p55 accessory subunit. J Biol Chem. 2001;276:38555–38562. doi: 10.1074/jbc.M105230200. [DOI] [PubMed] [Google Scholar]
- Longley MJ, Clark S, Yu Wai Man C, Hudson G, Durham SE, Taylor RW, Nightingale S, Turnbull DM, Copeland WC, Chinnery PF. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet. 2006;78:1026–1034. doi: 10.1086/504303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stotka JL, Straus SE, Hoofnagle JH. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med. 1995;333:1099–1105. doi: 10.1056/NEJM199510263331702. [DOI] [PubMed] [Google Scholar]
- Minor W, Cymborowski M, Otwinowski Z, Chruszcz M. HKL-3000: the integration of data reduction and structure solution–from diffraction images to an initial model in minutes. Acta Crystallogr D Biol Crystallogr. 2006;62:859–866. doi: 10.1107/S0907444906019949. [DOI] [PubMed] [Google Scholar]
- Murakami E, Feng JY, Lee H, Hanes J, Johnson KA, Anderson KS. Characterization of novel reverse transcriptase and other RNA-associated catalytic activities by human DNA polymerase gamma: importance in mitochondrial DNA replication. J Biol Chem. 2003;278:36403–36409. doi: 10.1074/jbc.M306236200. [DOI] [PubMed] [Google Scholar]
- Pinz KG, Bogenhagen DF. The influence of the DNA polymerase gamma accessory subunit on base excision repair by the catalytic subunit. DNA Repair. 2006;5:121–128. doi: 10.1016/j.dnarep.2005.08.014. [DOI] [PubMed] [Google Scholar]
- Richards FM. Areas, volumes, packing and protein structure. Annu Rev Biophys Bioeng. 1977;6:151–176. doi: 10.1146/annurev.bb.06.060177.001055. [DOI] [PubMed] [Google Scholar]
- Rouzier C, Chaussenot A, Serre V, Fragaki K, Bannwarth S, Ait-El-Mkadem S, Attarian S, Kaphan E, Cano A, Delmont E, Sacconi S, de Camaret BM, Rio M, Lebre AS, Jardel C, Deschamps R, Richelme C, Pouget J, Chabrol B, Paquis-Flucklinger V. Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort. Eur J Hum Genet. 2014;22:542–550. doi: 10.1038/ejhg.2013.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steitz TA, Steitz JA. A general two-metal-ion mechanism for catalytic RNA. Proc Natl Acad Sci USA. 1993;90:6498–6502. doi: 10.1073/pnas.90.14.6498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steitz TA. DNA polymerases: structural diversity and common mechanisms. J Biol Chem. 1999;274:17395–17398. doi: 10.1074/jbc.274.25.17395. [DOI] [PubMed] [Google Scholar]
- Steitz TA, Yin YW. Accuracy, lesion bypass, strand displacement and translocation by DNA polymerases. Philos Trans R Soc Lond B Biol Sci. 2004;359:17–23. doi: 10.1098/rstb.2003.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stumpf JD, Copeland WC. The exonuclease activity of the yeast mitochondrial DNA polymerase gamma suppresses mitochondrial DNA deletions between short direct repeats in Saccharomyces cerevisiae. Genetics. 2013;194:519–522. doi: 10.1534/genetics.113.150920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Subuddhi U, Hogg M, Reha-Krantz LJ. Use of 2-aminopurine fluorescence to study the role of the beta hairpin in the proofreading pathway catalyzed by the phage T4 and RB69 DNA polymerases. Biochemistry. 2008;47:6130–6137. doi: 10.1021/bi800211f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tabor S, Richardson CC. A single residue in DNA polymerases of the Escherichia coli DNA polymerase I family is critical for distinguishing between deoxy- and dideoxyribonucleotides. Proc Natl Acad Sci USA. 1995;92:6339–6343. doi: 10.1073/pnas.92.14.6339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vasta V, Merritt JL, Saneto RP, Hahn SH. Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum. Pediatr Int. 2012;54:585–601. doi: 10.1111/j.1442-200X.2012.03644.x. [DOI] [PubMed] [Google Scholar]
- Wang W, Wu EY, Hellinga HW, Beese LS. Structural factors that determine selectivity of a high fidelity DNA polymerase for deoxy-, dideoxy-, and ribonucleotides. J Biol Chem. 2012;287:28215–28226. doi: 10.1074/jbc.M112.366609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winterthun S, Ferrari G, He L, Taylor RW, Zeviani M, Turnbull DM, Engelsen BA, Moen G, Bindoff LA. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology. 2005;64:1204–1208. doi: 10.1212/01.WNL.0000156516.77696.5A. [DOI] [PubMed] [Google Scholar]
- Young MJ, Longley MJ, Li FY, Kasiviswanathan R, Wong LJ, Copeland WC. Biochemical analysis of human POLG2 variants associated with mitochondrial disease. Hum Mol Genet. 2011;20:3052–3066. doi: 10.1093/hmg/ddr209. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary Figures
Review Process File
